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Abstract 
  
 The epidermal growth factor receptor (EGFR) is a well-studied receptor tyrosine kinase and 
an important anticancer therapeutic target.  The activity of EGFR autophosphorylation and 
transphosphorylation, which induces several cell signaling pathways, has been suggested to 
be related to its oligomeric state.  However, the oligomeric states of EGFRs induced by EGF 
binding and the receptor–ligand stoichiometry required for its activation are still controversial.  
In the present study, we performed Förster resonance energy transfer (FRET) measurements 
by combining the coiled-coil tag–probe labeling method and spectral imaging to 
quantitatively analyze EGFR oligomerization on living CHO-K1 cell membranes at 
physiological expression levels.  In the absence of its ligands, EGFRs mainly existed as 
monomers with a small fraction of predimers (~10%), whereas ~70% of the EGFRs formed 
dimers after being stimulated with the ligand EGF.  Ligand-induced dimerization was not 
significantly affected by the perturbation of membrane components (cholesterol or 
monosialoganglioside GM3).  We also investigated both dose- and time- dependences of 
EGF-dependent EGFR dimerization and autophosphorylation.  The formation of dimers 
occurred within 20 s of the ligand stimulation and preceded its autophosphorylation, which 
reached a plateau 90 s after the stimulation.  The EGF concentration needed to evoke half 
maximum dimerization (~ 1 nM) was lower than that for half-maximum autophosphorylation 
(~ 8 nM), which suggested the presence of an inactive dimer binding a single EGF molecule. 
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1. Introduction 
  
The epidermal growth factor receptor (also called EGFR, ErbB1, or HER1) is one of the 
most well-studied receptor tyrosine kinases related to cell differentiation, proliferation, and 
other physiological activities via several signaling pathways, including the MAPK 
(mitogen-activated protein kinase) pathway [1].  EGFRs are important anticancer 
therapeutic targets because certain cancer tissues overexpress them, frequently with aberrant 
mutations [2–4].  The intracellular signaling pathways activated by EGFRs are triggered by 
homo/heterooligomerization between EGFRs or an EGFR and other ErbB family receptors, 
which results in the autophosphorylation/transphosphorylation of tyrosine residues at the C 
terminus of the receptors [5–7].  Previous studies using X-ray crystallography suggested that 
the extracellular domains of EGFRs may markedly change from a tethered form [8] to a 
extended form when EGFRs bind to their ligands: epidermal growth factor (EGF) or 
transforming growth factor-α [9,10].  However, the actual behavior of EGFRs on cell 
membranes upon ligand binding is more complex than a simple transition from unliganded 
inactive monomers to liganded active dimers [11–13].  Although the size of EGFR clusters 
is controversial, it is generally accepted that EGF binding enhances receptor oligomerization, 
which activates receptors.  Several studies reported that some EGFRs could form inactive 
dimers (predimer), even in the absence of a ligand [14–16].  EGFR dimers, higher-order 
oligomers, and aggregates have been identified in the activation process [15,17].  
Furthermore, there are a number of possibilities for stoichiometry of ligand and receptor that 
is required for the signaling.  One reason for the inconsistency in oligomeric states in the 
literature is the differences in the experimental conditions such as the host cells used and 
expression levels of the receptors.  For example, the dimer fraction in the absence of ligands 
can depend on the total concentration of receptors in the membrane because the unoccupied 
EGFR monomer is generally in equilibrium with the unoccupied EGFR dimer [13].  
Another reason for the apparent diversity has been attributed to limitations in the 
conventional methods used to evaluate the oligomerization of membrane proteins.  The 
solubilization by detergents or fixation of cells has been shown to significantly perturb 
interprotein interactions in native cell membranes [14,15].  For living cell analyses, energy 
transfer methods using genetic luminescent/fluorescent proteins sometimes provide 
controversial findings on the oligomeric states of target proteins because of a limited ability 
to control the labeling ratio of the energy donor to the acceptor [18]. 
 We here used EGFRs labeled with fluorophores by coiled-coil labeling [19] to clarify the 
oligomeric states of EGFRs in the activation process.  The coiled-coil method utilizes the 
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formation of a strong and specific noncovalent bond between the E3-peptide (EIAALEK)3 
fused to the N-terminus of the target protein and the fluorophore-conjugated K4-peptide 
(KIAALKE)4 (total size, 5–6 kDa).  This small post-translational labeling method can 
specifically detect cell-surface proteins in living cells.  We recently reported that a 
combination of the coiled-coil labeling method and Förster resonance energy transfer (FRET) 
measurements by spectral imaging enabled an exact analysis of the oligomeric states of target 
membrane proteins [20].  In the present study, we examined the relationship between the 
oligomeric states of EGFRs and their autophosphorylation levels to elucidate the activation 
mechanism. 
 
2. Materials and methods 
   
2.1. Preparation of K4 probes 
 
The K4 peptide (KIAALKE)4 was synthesized using a standard 
9-fluorenylmethyloxycarbonyl-based solid-phase method [19].  Each fluorophore (Alexa 
Fluor 568, Alexa Fluor 647, Tetramethylrhodamine, or Cy5 (Life Technologies, Carlsbad, 
CA)) was added to the N-terminus of the K4 peptide on resin by treating the fluorophores 
with succinimidyl ester derivatives [19].  After the fluorophore-conjugated peptides had 
been purified by reversed-phase HPLC, their molecular masses were confirmed by MALDI 
(Matrix-assisted laser desorption/ionization) mass spectroscopy.  The concentrations of the 
K4 probes were determined according to the absorbance of each fluorophore.  
 
2.2. Plasmid construction 
 
A DNA plasmid coding rat EGFR was constructed based on pcDNA3 (Life Technologies) 
by inserting the sequence of the E3-tagged EGFR (signal sequence-E3 tag-linker 
(ggcggcggcatcgat)-rat EGFR sequence-stop codon) at the multicloning site (see Table A1 in 
the Supporting Material).  Rat EGFR was cloned from the rat brain (see supplemental 
information).  Other pcDNA3-based plasmids containing E3-GpA* (G83I mutant) and 
E3-M2 were constructed as described previously [20].  A stable Flp-in CHO (Chinese 
hamster ovary) cell line expressing E3-β2AR (1.3 × 105 receptors/cell) [21] was used as an 
expression standard. 
 
2.3. Cell culture 
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CHO cells, which have only negligible endogenous ErbB family receptors [22–25], were 
used for the transient expression of membrane proteins.  CHO-K1 and Flp-in CHO cells 
(Life Technologies) stably expressing E3-β2AR were cultured in Ham’s F12 medium 
supplemented with 10% FBS, L-glutamine, penicillin, and streptomycin at 50 µg/mL at 37°C 
in a 5% CO2 incubator.  
 
2.4. Transient transfection 
 
CHO-K1 cells (1.0 × 105 per dish) were seeded in a 35-mm glass bottom dish (Advanced 
TC treated, Greiner Bio-one, Germany) and a polymer bottom dish for confocal imaging and 
immunoblotting, respectively.  The medium was changed to a serum-free medium after 
overnight incubation, and the cells were incubated with a transfection mixture composed of 
1.0 µg of plasmid DNA, 4.0 µL of Lipofectamine LTX (Life Technologies), and 400 µL of 
Opti-MEM (Life Technologies) per dish.  The medium of the CHO-K1 cells was changed to 
fresh medium containing 10% FBS 5 h after the transfection.  These cells were used in 
experiments 18 h after the transfection.  To eliminate the effects of growth factors included 
in FBS, E3-EGFR-expressing cells were serum-starved for at least 3 h before being 
examined. 
   
2.5. Immunoblotting 
 
After the transfection, E3-EGFR expressing cells were incubated with or without rat EGF 
(Higeta Shoyu, Tokyo, Japan) in PBS(+) (137 mM NaCl, 8.1 mM Na2HPO4, 2.68 mM KCl, 
1.47 mM KH2PO4, 0.9 mM CaCl2, 0.33 mM MgCl2, pH 7.4) for 5 min.  After removing 
PBS, the cells were lysed with 500 µL lysis buffer (1% SDS, 1 mM sodium orthovanadate, 
10 mM Tris-HCl (pH 7.4), protease inhibitor cocktail (Nacalai Tesque, Kyoto, Japan)) to stop 
the phosphorylation reaction.  Lysates were boiled for 5 min and centrifuged (21,900g, 5 
min).  Three µL of each supernatant was dropped on to the PVDF membranes.  After 
drying, the PVDF membranes were treated with the p-EGFR (Tyr1173) antibody (sc-101668, 
Santa Cruz Biotechnology, Dallas, TX) or EGFR antibody (sc-373746, Santa Cruz).  The 
secondary antibody labeled with horseradish peroxidase (anti-rabbit (sc-2004) or anti-mouse 
(sc-2005), Santa Cruz) was then added, and immunoreactive species were detected by the 
ECL reagent (Nacalai Tesque).  The phosphorylated-EGFR/total EGFR ratios of 
chemiluminescence intensities were used as the phosphorylation level.  In Western blotting, 
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20 µL of each lysate was applied to a 7% polyacrylamide gel.  After SDS-PAGE, the 
separated proteins were transferred onto PVDF membranes, which were then treated in the 
same manner as described above.  
 
2.6. Confocal microscopy 
 
All imaging experiments were performed using a Nikon C1 confocal microscope (Nikon, 
Tokyo, Japan) under a water-immersed 60× objective (Plan Apo VC) with 561 nm and 637 
nm lasers at room temperature (25–30 °C).  Cells expressing E3-tagged membrane proteins 
were labeled with a mixture of donor and acceptor fluorophores (Alexa568 and Alexa647) 
conjugated with K4 probes in PBS(+) (pH 7.4) for 5 min at room temperature after washing 
the cells once with PBS(+).  The proteins were labeled at various donor mole fractions (XD)    
and excited at 561 nm to obtain fluorescence emission spectra from the cell membranes 3 µm 
above the glass surface.  Spectral images in 565–745 nm (resolution: 10 nm) were obtained 
with a spectrum detector for following analysis of Eapp values.  In the binding assay of K4 
probes to the E3 tag fused with EGFR or β2AR, confocal images were obtained with a 
standard detector through a BP575 to 615 nm emission filter for the donor and a LP650 nm 
emission filter for the acceptor.  
 
2.7. Analysis of Eapp values from observed spectra 
 
We analyzed the oligomeric states of E3-tagged membrane proteins using FRET 
spectroscopy, as described in a previous study [20].  Briefly, we calculated FRET 
efficiencies based on sensitized emission of the acceptor fluorophores (Alexa647 or Cy5) 
from cell membranes. For the deconvolution of the observed spectra into donor and acceptor 
spectra, we separately obtained the reference spectra of the donor excited at 561 nm and 
acceptor excited at 637 nm from E3-GpA* (G83I mutant)-CHO (transient).  We use the 
least-squares method to perform deconvolution (see Fig. A4 and ref. 23).  Values of the 
apparent FRET efficiency based on sensitized acceptor emission (Eapp) were calculated with 
the equation based on the theory of Meyer et al.[26] 
 
                                               (1) 
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where εA(λDex) and εD(λDex) represent the molar extinction coefficient of the acceptor and 
donor at 561 nm, respectively, and FAD and FA indicate the acceptor emission intensity 
(arbitrary unit) excited at 561 nm in the presence and absence of the donor, respectively.  
Because FA could not be directly acquired in the presence of the donor, we also measured the 
ratio of the fluorescence intensities of the acceptor excited at 561 and 637 nm (R561/637) from 
the E3-GpA mutant (G83I)-CHO (transient) labeled with the acceptor, and then multiplied 
the fluorescence intensity of the acceptor acquired by the excitation at 637 nm in the presence 
of the donor by the R561/637 ratio to obtain the FA value. 
 
2.8. Theoretical curves 
 
Taking into account of random labeling of the donor and acceptor in the oligomers, the 
theoretical curve for Eapp is given [26], as 
 
                   (2) 
 
where XD, X’U, and N indicate the donor molar fraction over the total (donor and acceptor) 
molar concentration of the K4 probes, unlabeled receptor fraction, and the number of 
protomers in an oligomer, respectively.  The total molar concentrations of the K4 probes 
were set such that labeling efficiencies would be approximately 90% (100 nM for E3-EGFR 
and 50 nM for the other proteins).  The X’U value was estimated to be 0.1 based on the 
occupancies (~ 90%) of E3-tagged membrane proteins labeled with K4 probes at 50 nM (in 
the case of E3-β2AR /GpA*/M2) or 100 nM (E3-EGFR).  E represents the true FRET 
efficiency in the oligomers, which was determined by the distance and mutual orientation of 
the donor and acceptor.  The assumption of a random orientation of the fluorophores was 
reasonable because of flexible linkers (Gly–Gly–Gly–Ile–Asp) between the E3 tag and 
N-terminal regions. 
 
2.9. Depletion of sialic acid and cholesterol 
 
After transient transfection, E3-EGFR-expressing CHO-K1 cells were incubated for 2 h in 
serum-free medium, and then treated with 20 or 100 mU/mL of Arthrobacter ureafaciens 
neuraminidase (Nacalai Tesque) in serum-free medium for 1 h at 37 °C to deplete sialic acid 
levels.  To metabolically deplete cellular cholesterol, CHO-K1 cells were incubated with 1 
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µM compactin from seeding to examination, expect for the incubation time, with serum-free 
medium for 5 h after the transient transfection of EGFR.  Other procedures were the same as 
other FRET experiments. 
 
2.10. Time course of the FRET signal 
 
Time-lapse images were acquired to detect the time course of the EGFR oligomerization 
induced by the EGF stimulation.  After staining cells with Alexa-labeled K4 probes at XD = 
0.5 in 1 mL PBS(+) (pH 7.4) for 5 min at room temperature after washing the cells once with 
PBS(+), confocal images were obtained under excitation at 561 nm at 25–30 °C.  After 
taking the first three images (4 s intervals), 1 mL of PBS(+) containing the K4 probe (final 
concentration of 100 nM) and EGF (final concentration of 150 nM) were rapidly mixed with 
the sample, followed by the taking of images (2 s intervals).  The fluorescence spectra from 
cell membranes at each time point were deconvoluted into donor and acceptor spectra.  The 
ratio of the maximal fluorescence intensity of the acceptor (Em: 665 nm) to donor (Em: 605 
nm) (= A/D) was used as a measure of FRET. 
 
3. RESULTS  
  
3.1. EGFR expression and EGF-induced autophosphorylation 
 
Western blot analyses were performed to examine the expression of EGFRs and their 
phosphorylation activities in CHO-K1 cells.  E3-EGFRs were detected as single bands at 
approximately 175 kDa with both the anti-total EGFR antibody and anti-phosphotyrosine 
1173 antibody (see Fig. A1).  The intensities of the phosphorylated bands increased with 
increases in the concentration of EGF.  We confirmed that dot blotting gave similar results 
to Western blotting (see Fig. A1).  We performed dot blotting in subsequent experiments to 
determine the autophosphorylation levels of EGFRs.      
 
3.2. Labeling of EGFRs using the coiled-coil method 
 
CHO-K1 cells expressing E3-fused EGFRs were imaged by confocal microscopy after the 
specific labeling of cell-surface receptors with K4 probes (Fig. 1).  Most receptors remained 
in the plasma membrane during the observation time (5–25 min after incubation with or 
without EGF), although EGF-stimulation enhanced internalization (Fig. 1).  We analyzed 
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the fluorescence spectra in the cell membrane region in the following experiments.  The KD 
values between fluorophore-labeled K4 probes and E3-fused EGFRs (6–8 nM) were similar 
to those for other E3-tagged membrane proteins used in previous studies (~ 5 nM) (see Fig. 
A2).   To confirm that the E3–K4 complex did not affect EGFR activation, we examined 
EGF-induced EGFR autophosphorylation with and without K4 probes by immunoblotting.  
No significant difference was observed with the addition of K4 probes (see Fig. A3). 
 
Figure 1.  Confocal images of E3-tagged proteins.  Representative spectral images are 
shown in a pseudocolor.  E3-tagged proteins were transiently expressed and labeled with a 
1:1 mixture of a donor (Alexa568-K4) and acceptor (Alexa647-K4) (XD = 0.5) in PBS (+) 
(pH 7.4).  The total K4 probe concentration was 100 nM (EGFRs) or 50 nM (the other 
proteins).  All images were captured 5–25 min after labeling.  GpA* as a standard of a 
monomer is the G83I mutant of glycophorin A, which was derived from human erythrocytes.  
M2 as a standard of a dimer is the M2 proton channel derived from influenza A virus.  Rat 
EGFRs were stimulated with 150 nM of rat EGF.  Scale bar = 20 µm 
 
3.3. Analysis of oligomeric states 
 
To detect FRET induced by receptor oligomerization, we co-labeled E3-fused proteins on 
the cell surface with a pair of fluorophores with a large critical distance transfer (Alexa568 
and Alexa647, R0 = 82 Å) at various donor mole fractions (XD).  After the acquisition of 
spectral images by confocal microscopy, fluorescent spectra from the cell membranes (Fig, 
2A) were used to calculate the apparent FRET efficiency (Eapp) (Eq. 1).  A monomeric 
standard E3-GpA* (G83I mutant) showed Eapp values of nearly zero independent of XD, 
which was consistent with monomers (Fig. 2B).  We used the E3-M2 proton channel 
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derived from influenza A virus as a dimer standard because we recently found that E3-M2 
formed dimers at pH 7.4 [27].  These proteins were always used as monomer and dimer 
standards to confirm the reliability of the Eapp values of E3-EGFR.  We could determine Eapp 
values with an accuracy of ± 0.1 [20].  In the FRET analysis, we selected cells expressing a 
physiological level of EGFRs (5 × 104–2 × 105 receptors/cell) by comparing fluorescence 
intensities with those for reference cells stably expressing E3-β2AR (1.3 × 105 receptors/cell) 
[20] (see Fig. A5).  Eapp values for E3-EGFR were 0.1 or lower in the absence of EGF (Fig. 
2C).  On the other hand, in the presence of a saturating amount of EGF (150 nM), Eapp 
values increased linearly in a XD-dependent manner with a slope of 0.55 ± 0.03, which was 
lower than the theoretical value for the dimer with E = 1 (0.9).  The FRET signals already 
reached plateau 2 min after stimulation (see Fig. 4) and did not change significantly 5–25 min 
after the EGF stimulation (data not shown).  Partial dimerization (coexistence of monomers 
and dimers) and/or a larger donor–acceptor separation in the dimer than the R0 value of 82 Å 
(E < 1) may decrease the Eapp value of stimulated EGFRs.  To clarify the contributions of 
these two possibilities, we performed FRET experiments using another pair of fluorophores 
(TMR–Cy5), whose R0 value (53 Å) [28] was shorter than that of the Alexa pair.  In this 
case, the slope of Eapp was 0.25 ± 0.01 (Fig. 2D).  Because of a theoretically linear 
relationship between Eapp and XD, in the case of monomer–dimer transition, an observed 
value of Eapp is proportional to a dimer fraction at each XD.  The donor–acceptor distance (R) 
and corrected dimer fraction of EGFRs (f) were estimated by solving simultaneous equations 
for the Alexa and TMR–Cy5 pairs as below. 
 
                                       (3) 
 
We obtained R and f values of 56 Å and 0.67, respectively.  The value of R was plausible for 
a model that two K4 probes were tethered by the coiled-coil labeling and freely moved 
around the N termini of the EGFR back-to-back dimer, as determined by X-ray 
crystallography (~50 Å) [9].  One third of the EGFRs existed as monomers, even in the 
presence of sufficient EGF ligands.  Note that the FRET results do not exclude the 
possibility of local concentration (clustering) of the receptors into membrane domains 
without close contacts of the receptors (E = 0). 
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Figure 2.  Detection of the oligomeric states of membrane proteins by FRET.  (A) 
Fluorescence spectra (Ex : 561 nm) from cell membranes labeled with the Alexa-pair (XD = 
0.5).  Fluorescence spectra from at least 10 cells were averaged and normalized at 605 nm.  
Labeling conditions were the same as those described in Fig. 1.  The symbols indicate a 
GpA G83I mutant (black squares), M2 proton channel (blue squares), EGFR without EGF 
(red open circles), and EGFR with 150 nM EGF (red solid circles).  (B) Theoretical curves 
and measured Eapp values at various donor mole fractions (XD) using K4 probes labeled with 
the Alexa pair.  Black, blue, green, and yellow lines show theoretical curves for monomers, 
dimers, trimers and tetramers, respectively.  N indicates the number of protomers in an 
oligomer.  Black and blue squares indicate the Eapp values for GpA* and M2, respectively (n 
> 10).  (C) The Eapp values for EGFR with or without 150 nM EGF using K4 probes labeled 
with the Alexa pair.  Open and solid circles indicate values in the absence and presence of 
EGF, respectively (n > 10).  The plots were linearly fit to obtain the slopes.  (D) 
Comparison of Eapp values for EGFR labeled with the Alexa pair (red) and the TMR–Cy5 
pair (green).  Open and solid symbols indicate values in the absence and presence of EGF, 
respectively (n > 10). 
 
 
3.4. Effects of membrane components on EGFR dimerization 
 
Membrane components such as cholesterol and ganglioside GM3 have been considered as 
functional modulators for EGFRs and other tyrosine-kinase receptors [29,30].  We 
examined the relationship between EGFR dimerization and the presence of cholesterol or 
GM3 by measuring Eapp values at XD = 0.74 after the treatment with the lipid-disrupting 
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reagents.  The compactin-induced depletion of cholesterol had no significant effect on the 
Eapp value in the presence of EGF (Fig. 3).  Similarly, the degradation of GM3 by the 
treatment with up to 100 mU/mL neuraminidase did not significantly affect the Eapp value 
with 150 nM EGF (Fig. 3). 
 
Figure 3.  Eapp values after the depletion of cholesterol or monosialoganglioside GM3.  All 
experiments were performed at XD = 0.74.  Fluorescence spectra from EGF-stimulated 
CHO-K1 cells were observed 5–25 min after the EGF stimulation.  Each value indicates the 
mean ± SE. (n > 10). 
 
3.5. Time course of EGFR oligomerization and phosphorylation 
 
We detected rapid receptor oligomerization following ligand stimulation with the 
acceptor/donor fluorescence intensity ratio (A/D).  Upon adding EGF to cells, the A/D value 
increased from the baseline (~ 0.08) to a plateau (~ 0.14) values within 20 s (Fig. 4).  The 
ratio did not change for at least 3 min after reaching the plateau.  On the other hand, the 
EGFR phosphorylation level, examined by dot blotting, exhibited a slower increase than the 
FRET signal, and reached a plateau at approximately 90 s (Fig. 4).  Note that the 
ligand-independent basal phosphorylation of EGFR in the absence of EGF exhibited the 
non-zero value (0.2–0.4) (Fig. 4 and Fig. 5A) supposedly due to cells overexpressing 
receptors, which were excluded in the confocal microscopy-based analyses, whereas 
ligand-induced phosphorylation should represent the response from cells expressing 
physiological amount of receptors. 
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3.6. Dose-response curves 
 
Finally, we examined the EGF concentration-dependence of EGFR dimerization at XD = 
0.74.  We determined Eapp values of EGFRs after 5–25 min stimulation with different 
concentrations of EGF in the presence of the Alexa K4 probes pair.  Percentages of EGFR 
dimers (dimer fraction at each EGF concentration (f) × 100) were calculated as 
 
    (4) 
 
Where Eapp,obs is an observed value of Eapp, Eapp,dimer is the theoretical value of Eapp 
considering all EGFRs form dimers.  E (= 1 / (1 + (R/R0)6) is the true FRET efficiency in the 
dimer considering R = 56 Å and R0 = 82 Å. XD and X’U were fixed at 0.74 and 0.1, respectively.  
The dimerization of EGFRs significantly increased in an EGF concentration range between 1 
nM and 10 nM (an apparent 50% effective dose was ~ 1 nM) (Fig. 5A).  At higher 
concentrations of EGF (> 10 nM), the fraction of dimerized EGFRs was approximately 67% 
(55–75%).  On the other hand, an apparent 50% effective dose of EGFR phosphorylation 
determined by immunoblotting was ~ 8 nM (Fig. 5A).    
 
Figure 4.  Time courses of dimerization and phosphorylation upon stimulation.  A/D is the 
ratio of the maximal fluorescence intensities of the acceptor (665 nm) to the donor (605 nm), 
which were obtained from the deconvoluted fluorescence spectra (Ex : 561nm) of four cell 
membranes.  Labeling was performed at XD = 0.5.  The phosphorylation level was the  
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relative chemiluminescence intensity for phosphorylated Tyr1173 to total EGFR as 
determined by dot blotting after the stimulation was stopped at each time point by the 
addition of the lyse buffer.  The phosphorylation level was an average from three separately 
performed experiments.  Each value indicates the mean ± SE. (n > 3). 
 
Figure 5.  EGF dose-dependent dimerization and phosphorylation of EGFRs.  (A) The EGF 
concentration dependencies of EGFRs.  Blue: Oligomerization 5–25 min after EGF 
stimulation.  Red: Phosphorylation 5 min after EGF stimulation of EGFRs.  The 
phosphorylation level was obtained from dot blotting (see fig A1, B).  The dimer fraction 
was calculated from Eapp values at XD = 0.74, assuming R = 56 Å.  Each value indicates the 





4.1. Oligomeric states of EGFRs 
 
The mechanism underlying EGFR oligomerization is not simple because the strength of 
ligand affinity and receptor self-association are intricately related to each other.  For 
example, negative cooperativity has been reported for the ligand binding of EGFRs [11–13], 
which indicates that EGFRs have two distinguishable binding sites to their ligand and binding 
of the ligand to the first site reduces affinity for the second site [13].  Moreover, the degree 
of oligomerization generally depends on the expression level according to the association 
constants [13].  Under our experimental conditions (5 × 104–2 × 105 receptors/cell), EGFRs 
appeared to exist as monomers or dimers without forming higher-order oligomers, because 
the Eapp plot of EGFR with 150 nM EGF gave the best fit with a linear shape (fig. 2C and D), 
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which is characteristic of the dimer. On the other hand, downward-convex curves are 
characteristic of the trimer or higher oligomers (fig. 2B).  The majority of EGFRs could be 
regarded as monomers in the resting state (~ 90%) with a small fraction of predimers (~10%), 
whereas ~70% of the EGFRs formed dimers after ligand stimulation.  The observed degrees 
of oligomerization appear to be lower than those in previous reports describing significant 
formation of predimers and higher-order oligomers in the absence of EGF [31,32].  The host 
cell line and the expression level can significantly affect the oligomeric and clustering states 
of the receptors.  Clayton and coworkers reported tetramers (or higher order oligomers) of 
unligated EGFR in epidermoid carcinoma A431 cells [31].  On the other hand, Saffarian et 
al. reported ~70% monomeric EGFRs in the resting state in CHO cells [32].  In our 
experiments, the coiled-coil labeling may slightly interfere the oligomerization to 
underestimate the oligomer population, although the N-termini were separated in the dimer 
(~56 Å, estimated from Equation 3), and the K4 labeling did not affect the phosphorylation of 
the receptors (Fig. A3). 
 
4.2. Factors affecting EGFR dimerization 
 
The monomer–dimer transition of EGFRs may be regulated by several factors other than the 
receptor concentration.  One possible reason why not all EGFRs formed dimers following 
the EGF stimulation is the interaction between plasma membrane components and EGFRs.  
Cholesterol and GM3 have been shown to interact with EGFRs, thereby diminishing 
ligand-induced EGFR phosphorylation, whereas the removal of cholesterol from cell 
membranes or degradation of GM3 increased EGFR phosphorylation [29,30].  Therefore, it 
is plausible to assume that these lipids suppress receptor oligomerization.  However, we 
observed no significant effect of the depletion of cholesterol or GM3 on the oligomeric states 
of EGFRs in the presence of 150 nM EGF (Fig. 3).  These results suggest that cholesterol 
and GM3 had no effect on EGFR dimerization in ligand-occupied extended EGFRs.  These 
results indicate that these two membrane components inhibit EGFR phosphorylation by 
different mechanisms from the regulation of oligomeric states.  Other factors may explain 
the co-existence of EGFR monomers and dimers after the ligand stimulation.  The 
extracellular domain of EGFRs may remain a steric hindrance to dimerization to some extent.  
A previous study reported that an EGFR mutant lacking much of the EGFR extracellular 
domain exhibited stronger phosphorylation activity than that of the wild-type regardless of 
the ligand stimulation [33].  Furthermore, the cationic residues of the kinase domain may 
interact with anionic lipids (e.g., phosphatidylserine) on the inner leaflet to hinder EGFR 
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dimerization, although the intracellular domains of EGFRs also exhibit dimerizing abilities 
[7].  EGFR phosphorylation can also enhance the dissociation of dimers into monomers 
[13,34].  In the present study, the fluorescence spectra acquired from the cell membrane 
contained temporally averaged information regarding the EGFR oligomeric state.  Therefore, 
it remains unclear whether the coexistence of monomers and dimers reflects two static 
species or a dynamic equilibrium between them.  Single molecule studies reported that 
dimers were not very stable (lifetimes in the order of seconds), even in the ligand-bound form 
[35].  Therefore, at least some of the EGF-resistant monomers observed should be in 
dynamic equilibrium with dimers. 
 
4.3. Relationship between EGFR dimerization and phosphorylation 
 
As far as we know, it is the first time to investigate quantitatively the relationship of 
time-courses of the EGFR dimerization and autophosphorylation induced by EGF stimulation. 
The receptors rapidly oligomerized within 20 s after EGF stimulation (Fig. 4).  EGF 
association rate was estimated by using reported rate constants for high-affinity and low 
affinity sites [36,37].  In our condition of 150 nM EGF, the observed oligomerization rate (k 
~ 0.1 sec–1, Figure 4) was comparable or lower than the binding rates for both high-affinity 
(khigh = 0.23–60 sec–1) and low-affinity (klow = 0.084–0.6 sec–1) sites, although the formation 
of low-affinity inactive dimer may prevent complete ligand binding to all receptors (see 
below).  The theoretical random collision rate of EGFR monomers is sufficiently fast (k = 
5.6 sec–1) and can explain the quick dimerization under the experimental conditions 
(calculated according to Eq. 13b of reference [38], assuming receptors per cell of 50,000 with 
a cell diameter of 20 µm, critical collision distance of 1 nm, and a diffusion coefficient [35] 
of 0.05 µm2 sec–1).  The delayed EGFR phosphorylation upon ligand binding revealed that 
EGFR dimerization preceded its phosphorylation (Fig. 4).  This finding is consistent with 
the conventional view that EGFR autophosphorylation requires the formation of the 
asymmetric kinase domain dimers [7].  Moreover, as shown in Fig. 5A, the dose-response of 
EGFR dimerization shifted to the left of the phosphorylation curve.  Considering that a 
subnanomoler range of EGF can trigger significant signaling by binding to the high-affinity 
site [37,46], the saturation of phosphorylation should require sufficient EGF binding to the 
low-affinity site, although it may not be related to signaling in physiological conditions.  
The apparent 50% effective doses of EGFR dimerization and phosphorylation were 
approximately 1 nM and 8 nM, respectively, with the former being within the reported 
apparent binding affinities (KD) of EGFR to its ligand (0.27–5 nM [39–43]).  The latter 
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less-sensitive phosphorylation activities have also been reported in literatures [44,45].  
These results confirm that the N-terminal coiled-coil labeling did not significantly affect the 
receptor function.  EGFRs were significantly dimerized while maintaining the basal 
phosphorylation level especially at 1 nM of EGF.  A formation of kinase-inactive dimers 
may explain the experimental observation.  A possible model for this inactive dimer is an 
EGFR dimer that binds to a single EGF, which can be activated by the binding of a second 
ligand (Fig. 5B).  A ligand-occupied EGFR monomer was more likely to encounter an 
unoccupied monomer at EGF concentrations of 1–10 nM, and they could form an inactive 
dimer with a single ligand.  This observation is consistent with negative cooperativity for 
the ligand binding to EGFRs [11–13].  On the other hand, other studies have shown that low 
receptor occupancy is sufficient to trigger signaling, suggesting that EGF binding to high 
affinity receptors has positive cooperativity [36,37,46].  We propose a hypothetical model to 
explain these observations.  In this model, binding of an EGF to the predimer (~10% in this 
study) accelerates binding of the second EGF and rapid activation (high-affinity dimer with 
positive cooperativity) [36], whereas association of EGF-bound monomer to unbound 
monomer decelerates the binding of the second ligand (ligand-induced low-affinity dimer 
with negative cooperativity) (Fig. 5B).  In previous models, these single-liganded dimers are 
not discriminated as different species [5,12,36,47].  The interconversion between these 
species may be slowed down due to steric hindrance in the dimers.  Liu et al. showed that 
EGFR dimers occupied with a single EGF can be phosphorylated by means of cotransfection 
of two kinds of EGFR mutants that lack the ligand-binding or kinase activity, respectively 
[48], but they did not examine the ratio of phosphorylated single-occupied dimers over all 
dimers in the experimental condition.  Moreover, a phosphorylation level of the 
single-occupied dimer mutants was significantly lower than that of dimers of intact EGFRs in 
the presence of EGF.  It is also unclear whether the difference of phosphorylation levels 
between the single-occupied dimer mutants in the presence and absence of EGF was 
significant or not in this report [48].  Considering the Liu’s report, the single-occupied 
dimers may have partial phosphorylation activity, however the main source of EGFR 
phosphorylation was the double occupied dimers at least in the presence of 1 nM or higher 




We succeeded in elucidating the oligomeric states of EGFRs on living CHO cell membranes 
using a combination of the coiled-coil method and FRET analysis based on confocal spectral 
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microscopy.  Comparing with other previous reports on EGFR activities we emphasize that 
this approach is quantitative and enables time-resolved analysis for living cells.  Our results 
showed that the majority of EGFRs assumed a monomer form in the absence of their ligands 
with a small fraction of predimer (~10%).  The ligand stimulation led to ~60% of EGFRs 
altering their oligomeric state from monomers to dimers, while the remaining receptors 
existed as monomers.  The formation of dimers by the ligand stimulation preceded its 
phosphorylation in both time and ligand-dose dependent manners.  These results indicate 
that the formation of EGFR dimers induced by the ligand stimulation plays a major role in 
EGFR autophosphorylation.  Regarding the clinical importance of EGFRs, several kinds of 
cancerous cells overexpress EGFRs (e.g., A431 cells (> 2 × 106 receptors/cell) [49]) or have 
pathogenic EGFR mutations [50].  The method used in this study could reveal the behavior 
of EGFRs in the context of these malignant cells.  Moreover, the coiled-coil labeling 
method could be applicable to other ErbB family receptors and other membrane proteins, so 
this approach could help to understand comprehensively the interactions of EGFRs and other 
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DNA oligonucleotide sequences for the construction of E3-ratEGFR-pcDNA3 (Table A1), 
immunoblotting of EGFR (Fig. A1), binding assay for K4 probes (Fig. A2), EGFR 
autophosphorylation activity with/without a K4 probe (Fig. A3), deconvolution of observed 
spectra from the membrane with K4 probes at XD = 0.5 (Fig. A4), expression level of 
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Table A1.  List of DNA oligonucleotide sequence for the construction of 
E3-ratEGFR-pcDNA3 




                                            
1Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, 
Japan 
2Corresponding author. 
DNA name Sequence (5’-3’) 
Fwd-sig ttGAATTCccaccatgctgcgaggccagcggcac 
  EcoRⅠ        rat TrkA signal sequence 
Rev-sig cctaagCTCGAGggatgcggcgcaagcacaagcc 
      XhoⅠ     rat TrkA signal sequence 
Fwd-E3 tag CTCGAGgaaatcgccgctctggaaaaagagatcgctgctctggagaaggagattgccgcccttgagaagggcggcggcATCGATt 
XhoⅠ     E3 tag	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	  	 ClaⅠ 
Rev-E3 tag ctagaATCGATgccgccgcccttctcaagggcggcaatctccttctccagagcagcgatctctttttccagagcggcgatttcc 
     ClaⅠ              E3 tag 
Fwd-EGFR gtATCGATctggaggaaaagaaagtttgccaagg  
  ClaⅠ     EGFR 
Rev-EGFR atGCTAGCtcatgctccactaaactcactgcttg 
	 NheⅠ    EGFR 
Fwd-RE CGATtccggaGCTAGCaccggtgcggccgcgatatcgttaact   
ClaⅠ        NheⅠ  
Rev-RE CTAGAgttaacgatatcgcggccgcaccggtGCTAGCtccggaat 




Construction of a Plasmid Containing E3-ratEGFR-pcDNA3   
All DNA primers used are listed in table S1.  Total RNA from PC12 cells was purified 
using the RNeasy Mini Kit (Qiagen, Maryland, USA).  The cDNA encoding kozak 
sequence, followed by the rat TrkA signal sequence were obtained from total RNA using 
RT-PCR with primers (Fwd-sig and Rev-sig).  The cDNA encoding rat EGFR (NCBI 
Reference Sequence: NM_031507.1) from the rat brain was also obtained using Fwd-EGFR 
and Rev-EGFR.  The Fwd-E3 tag and Rev-E3 tag were annealed to each other and ligated 
into the Xho I –Xba I site of pcDNA3, and Fwd-RE and Rev-RE were then annealed and 
ligated into the Cla I –Xba I site located downstream of the E3 tag sequence.  The cDNA 
encoding rat TrkA signal sequence was ligated into the EcoR I –Xho I site located upstream 
of the E3 tag sequence.  The cDNA encoding rat EGFR was ligated into the Cla I –Nhe I 
site located downstream of the E3 tag sequence.  Sequence of the final product was verified 
using a DNA sequencer. 
 
Effects of the K4 Probe on EGFR Autophosphorylation 
E3-EGFR-expressing cells were prepared as described in the Materials and Methods.  After 
3h of serum starvation, cells were incubated with 0.5 mL of PBS containing 0 or 100 nM 
Alexa568-K4 for 5 minutes.  A total of 0.5 mL of PBS containing 0 or 150 nM EGF and 0 
or 100 nM Alexa568-K4 was then added into cells for 5 minutes at room temperature.  After 
removing PBS, the cells were lysed and used for immunoblotting as described in the 
Materials and Methods. 
 
Binding Assay for K4 Probes  
CHO cells expressing E3-β2AR (stable) or E3-EGFR-CHO (transient) were placed in a 
35-mm glass bottom dish.  The cells were labeled with a K4 probe at concentrations of 2.5, 
10, 20, 50, and 100 nM. After a 5 min incubation at room temperature, confocal images were 
acquired using the Nikon C1 confocal microscope to obtain the fluorescence intensity of the 
cell surface.  KD values of K4 probes and the occupancies of E3-tagged receptors labeled 
with K4 probes were determined as 
                                            (S1) 
 
where [R] denotes the amount of K4 probe-bound E3-receptors, [R]total indicates the amount 





approached asymptotically in the saturation curves, [P]free is the free concentration of K4 
probes, and KD is the dissociation constant.  In order to correct the EGFR expression level 
of each cell, fluorescence intensities after labeling with 100 nM of the K4 probe were also 







Figure A1. Western blotting (A) and dot blotting (B) of EGFR 
Chemiluminescence detected by the anti-total EGFR antibody (sc-373746) or 
anti-phosphotyrosine 1173 antibody (sc-101668).  Before lysing, samples were incubated 





Figure A2.  Binding assay for the K4 probes 
Fluorescence intensities obtained from the plasma membranes were plotted as a function of 
K4 probe concentrations. Solid curves show a fit with eq. S1.  Error bars indicate the 
standard errors.  In the case of E3-EGFR, fluorescence intensities were normalized by the 
EGFR expression level on each cell membrane.  (A) Binding curve for E3-EGFR and 
Alexa568-K4.  KD = 5.8 ± 0.3 nM (n = 4).  (B) Binding curve for E3-EGFR and 
Alexa647-K4.  KD = 8.3 ± 2.0 nM (n = 4).  (C) Binding curve for E3-EGFR and TMR-K4.  
KD = 4.4 ± 0.5 nM (n = 6).  (D) Binding curve for E3-EGFR and Cy5-K4.  KD = 3.4 ± 0.5 



















Figure A3.  EGFR autophosphorylation activity with/without a K4 probe. Error bars 















Figure A4.  Deconvolution of observed spectra from the membrane with K4 probes at XD = 
0.5  
Representative spectra for (A) E3-β2AR-CHO (stable), (B) E3-GpA*-CHO (transient), (C) 
E3-M2-CHO (transient), and E3-EGFR-CHO (transient) with (D) or without (E) 150 nM 
EGF, respectively.  Black, green, red, and blue lines show the observed spectra, the 
deconvoluted spectral components of the donor, that of the acceptor, and the spectra expected 













Figure A5.  Effects of the expression levels of E3-fused proteins on Eapp values 
The Y-axis indicates Eapp at XD = 0.74.  The X-axis denotes the expression levels of 
E3-tagged proteins calculated from fluorescence intensities (Ex: 647 nm / Em: 665 nm) (The 
averaged fluorescence intensity from E3-β2AR-CHO was considered to be 1.3×105 
receptors/cell).  Eapp values were not dependent on expression levels, which were 
maintained under the physiological levels.  (A) E3-β2AR-CHO (stable), (B) E3-GpA*-CHO 
(transient), (C) E3-M2-CHO (transient), and E3-EGFR-CHO (transient) with (D) or without 
(E) 150 nM EGF, respectively (n = 10). 
